Caligan Partners LP Has $15.72 Million Stake in Y-mAbs

Dec 1, 2024 · Caligan Partners LP boosted its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB - Free Report) by 105.3% during the third quarter, according to its most …

3%
OFF

Caligan Partners LP Has $15.72 Million Stake In Y-mAbs

2 weeks from now

Dec 1, 2024 · Caligan Partners LP boosted its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB - Free Report) by 105.3% during the third quarter, according to its most …

marketbeat.com

3%
OFF

Y-mAbs Therapeutics (NASDAQ:YMAB) Coverage Initiated By

2 weeks from now

Nov 18, 2024 · The firm has a market capitalization of $480.14 million, a P/E ratio of -20.35 and a beta of 0.68. ... Caligan Partners LP increased its stake in Y-mAbs Therapeutics by 105.3% in …

marketbeat.com

3%
OFF

Caligan Partners LP Raises Stake In Y-mAbs Therapeutics, Inc

2 weeks from now

Dec 1, 2024 · Caligan Partners LP boosted its holdings in shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 105.3% in the 3rd quarter, according to the company in its …

techdows.com

3%
OFF

Analysts Set Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Price …

2 weeks from now

Dec 19, 2024 · Finally, Caligan Partners LP increased its holdings in shares of Y-mAbs Therapeutics by 105.3% in the 3rd quarter. Caligan Partners LP now owns 1,195,253 shares …

americanbankingnews.com

$472.09
OFF

Y-mAbs Therapeutics (NASDAQ:YMAB) Research Coverage Started …

2 weeks from now

Dec 8, 2024 · The company has a market capitalization of $472.09 million, a PE ratio of -19.52 and a beta of 0.61. ... Caligan Partners LP grew its position in Y-mAbs Therapeutics by …

americanbankingnews.com

$15718000
OFF

Y-mAbs Therapeutics’ (YMAB) Buy Rating Reaffirmed At HC …

2 weeks from now

Nov 16, 2024 · Caligan Partners LP now owns 1,195,253 shares of the company’s stock valued at $15,718,000 after purchasing an additional 613,175 shares during the period. Geode Capital …

mayfieldrecorder.com

3%
OFF

Brokerages Set Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Target …

2 weeks from now

Dec 19, 2024 · Caligan Partners LP lifted its holdings in shares of Y-mAbs Therapeutics by 105.3% during the 3rd quarter. ... The stock has a market cap of $393.25 million, a P/E ratio of …

etfdailynews.com

3%
OFF

HC Wainwright Reaffirms “Buy” Rating For Y-mAbs Therapeutics …

2 weeks from now

Dec 13, 2024 · The firm has a market cap of $437.60 million, a P/E ratio of -18.09 and a beta of 0.61. ... Caligan Partners LP grew its stake in shares of Y-mAbs Therapeutics by 105.3% in …

etfdailynews.com

$9.55
OFF

Top 10 Holdings Of Caligan Partners - Insider Monkey

2 weeks from now

Aug 8, 2024 · Caligan Partners’ Equity Stake: $9.55 Million. Number of Hedge Fund Holders: 11. Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is one of the top 10 holdings of Caligan …

insidermonkey.com

$18.46
OFF

Y-mAbs Therapeutics (YMAB) News Today - MarketBeat

2 weeks from now

Jan 8, 2025 · Caligan Partners LP Raises Stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) ... The business had revenue of $18.46 million for the quarter, compared to analyst estimates …

marketbeat.com

$9.55
OFF

Y-mAbs Therapeutics, Inc. (YMAB): One Of Caligan Partners’ Top

2 weeks from now

Caligan Partners' Equity Stake: $9.55 Million Number of Hedge Fund Holders: 11 Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is one of the top 10 holdings of Caligan Pharmaceuticals …

msn.com

$14.17
OFF

Top 10 Holdings Of Caligan Partners - Insider Monkey

2 weeks from now

Aug 8, 2024 · Caligan Partners’ Equity Stake: $14.17 Million Number of Hedge Fund Holders: 30 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is a biopharmaceutical company that discovers …

insidermonkey.com